Owlstone Medical tipped as potential ‘Unicorn’ in The Spectator
Martin Vander Weyer tipped Owlstone as one of four high-tech start-ups with a chance of becoming the next "unicorn" - a British company that will be worth a billion dollars by the middle of the next decade.
Published on: 8 Aug 2016
Writing in The Spectator on 30 July 2016, Martin Vander Weyer tipped Owlstone as one of four high-tech start-ups with a chance of becoming the next “Unicorn” – a British company that will be worth a billion dollars by the middle of the next decade.
(Owlstone is mentioned about halfway through underneath the subheading “The unicorn hunt”.)